Unraveling resistance to CDK4/6 inhibitors in ovarian cancer

Unraveling resistance to CDK4/6 inhibitors in ovarian cancer

Source: News-Medical

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, necessitating new therapeutic strategies.

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, necessitating new therapeutic strategies. CDK4/6 inhibitors show promise but their efficacy varies, highlighting the need fo… [1889 chars]

Read more

Leave a Comment

Your email address will not be published.

0